IRIS
RONCATO, Rossana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 853
AS - Asia 600
EU - Europa 504
SA - Sud America 99
AF - Africa 24
Totale 2.080
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 840
SG - Singapore 266
CN - Cina 129
IT - Italia 117
HK - Hong Kong 107
BR - Brasile 90
RU - Federazione Russa 88
DE - Germania 62
IE - Irlanda 46
KR - Corea 40
FR - Francia 31
GB - Regno Unito 30
FI - Finlandia 25
IN - India 24
NL - Olanda 19
UA - Ucraina 17
CH - Svizzera 16
TG - Togo 15
AT - Austria 14
CZ - Repubblica Ceca 11
TR - Turchia 9
CA - Canada 8
ES - Italia 7
SE - Svezia 6
AR - Argentina 4
BD - Bangladesh 4
BE - Belgio 3
IQ - Iraq 3
LT - Lituania 3
MX - Messico 3
VN - Vietnam 3
AO - Angola 2
DK - Danimarca 2
MA - Marocco 2
OM - Oman 2
PL - Polonia 2
SA - Arabia Saudita 2
UZ - Uzbekistan 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CL - Cile 1
CO - Colombia 1
CR - Costa Rica 1
EC - Ecuador 1
EG - Egitto 1
GE - Georgia 1
IL - Israele 1
IR - Iran 1
KE - Kenya 1
KZ - Kazakistan 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
PS - Palestinian Territory 1
PT - Portogallo 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
VE - Venezuela 1
Totale 2.080
Salva come PNG Salva come JPEG
Città #
Singapore 186
Hong Kong 106
Boardman 75
Fairfield 69
Chandler 68
Ashburn 63
Beijing 51
Dublin 46
Hefei 40
Seoul 40
Houston 38
Woodbridge 38
Cambridge 32
Seattle 30
Wilmington 27
Los Angeles 24
Munich 18
Zurich 16
Lomé 15
Nuremberg 15
Ann Arbor 14
London 14
Dearborn 13
Frankfurt am Main 12
Ogden 12
Pune 12
Genoa 11
Brno 10
Dallas 10
Helsinki 9
Princeton 9
Arezzo 8
Redmond 8
Turku 8
Amsterdam 7
Hyderabad 7
Lauterbourg 7
Santa Clara 7
São Paulo 7
Vienna 7
Jacksonville 6
New York 6
Portsmouth 6
Udine 6
Belluno 5
Belo Horizonte 5
Brooklyn 5
Des Moines 5
Düsseldorf 5
Lappeenranta 5
Milan 5
Cormons 4
Deiva Marina 4
Guarulhos 4
Izmir 4
Xi'an 4
Zoppola 4
Brasília 3
Brussels 3
Codroipo 3
Cologne 3
Guangzhou 3
Madrid 3
Naples 3
Shenzhen 3
Thetford 3
Toronto 3
Azzano Decimo 2
Bologna 2
Boston 2
Charlotte 2
Chicago 2
Gorgonzola 2
Hanoi 2
Innsbruck 2
Leawood 2
Lissone 2
Luanda 2
Mirano 2
Monza 2
Muscat 2
Newark 2
Novara 2
Porcia 2
Rio de Janeiro 2
Riyadh 2
Roccamonfina 2
Romans d'Isonzo 2
Rome 2
San Diego 2
San Francisco 2
San Giorgio di Nogaro 2
Stockholm 2
Tashkent 2
Tulle 2
Urbino 2
Vaestra Froelunda 2
Venice 2
Vercelli 2
Volta Redonda 2
Totale 1.368
Salva come PNG Salva come JPEG
Nome #
Clonal Evolution of TP53 c.375+1G>A Mutation in Pre- and Post- Neo-Adjuvant Chemotherapy (NACT) Tumor Samples in High-Grade Serous Ovarian Cancer (HGSOC) 128
Estimating the Effectiveness of DPYD Genotyping in Italian Individuals Suffering from Cancer Based on the Cost of Chemotherapy-Induced Toxicity 107
A TGF-β associated genetic score to define prognosis and platinum sensitivity in advanced epithelial ovarian cancer 96
The use of pharmacogenetics to increase the safety of colorectal cancer patients treated with fluoropyrimidines 85
DPYD gene activity score (GAS) predicts dose-limiting toxicity in fluoropyrimidine-treated colorectal cancer patients 80
Is ctDNA ready to outpace imaging in monitoring early and advanced breast cancer? 67
The Genotype for DPYD Risk Variants in Patients With Colorectal Cancer and the Related Toxicity Management Costs in Clinical Practice 59
SMAD3 Host and Tumor Profiling to Identify Locally Advanced Rectal Cancer Patients at High Risk of Poor Response to Neoadjuvant Chemoradiotherapy 54
An Integrated Pharmacological Counselling Approach to Guide Decision-Making in the Treatment with CDK4/6 Inhibitors for Metastatic Breast Cancer 53
FARMAPRICE: A Pharmacogenetic Clinical decision support system for precise and Cost-Effective Therapy 53
Association of ADME gene polymorphisms on toxicity to CDK4/6 inhibitors in patients with HR+ HER2- metastatic breast cancer 51
Rare genetic variant burden in DPYD predicts severe fluoropyrimidine-related toxicity risk 51
A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study 47
CYP2D6 and CYP2C8 pharmacogenetics and pharmacological interactions to predict imatinib plasmatic exposure in GIST patients 46
Therapeutic Monitoring of Palbociclib, Ribociclib, Abemaciclib, M2, M20, and Letrozole in Human Plasma: A Novel LC-MS/MS Method 46
JAK-Inhibitors for the Treatment of Rheumatoid Arthritis: A Focus on the Present and an Outlook on the Future 43
Abstract PD10-01: Impact of ESR1 mutations on Selective Estrogen Receptor Degraders and Modulators: an integrated liquid-biopsy and pharmacodynamics approach 43
Clinical impact of body mass index on palbociclib treatment outcomes and effect on exposure 42
A Systematic Review and a Meta-Analysis Comparing Prophylactic and Therapeutic Low Molecular Weight Heparins for Mortality Reduction in 32,688 COVID-19 Patients 38
Cost Evaluation of Irinotecan-Related Toxicities Associated With the UGT1A1*28 Patient Genotype 37
The challenge of molecular selection in liver-limited metastatic colorectal cancer for surgical resection: a systematic review and meta-analysis in the context of current and future approaches 37
Germline and Somatic Pharmacogenomics to Refine Rectal Cancer Patients Selection for Neo-Adjuvant Chemoradiotherapy 37
Lipid rafts as viral entry routes and immune platforms: A double-edged sword in SARS-CoV-2 infection? 36
IL15RA and SMAD3 Genetic Variants Predict Overall Survival in Metastatic Colorectal Cancer Patients Treated with FOLFIRI Therapy: A New Paradigm 36
Implementation of preemptive testing of a pharmacogenomic panel in clinical practice: Where do we stand? 34
Therapeutic drug monitoring for the cancer patient: challenges and opportunities 33
Unlocking the potential of Molecular Tumor Boards: from cutting-edge data interpretation to innovative clinical pathways 33
LC-MS/MS Method for the Quantification of PARP Inhibitors Olaparib, Rucaparib and Niraparib in Human Plasma and Dried Blood Spot: Development, Validation and Clinical Validation for Therapeutic Drug Monitoring 33
NAFLD-Related Hepatocarcinoma: The Malignant Side of Metabolic Syndrome 33
The use of therapeutic drug monitoring to highlight an over-looked drug-drug interaction leading to imatinib treatment failure 32
Pharmacovigilance, drug interactions, pharmacogenetics and therapeutic drug monitoring of anticancer agents: a valuable support for clinical practice 32
New Challenges in Tumor Mutation Heterogeneity in Advanced Ovarian Cancer by a Targeted Next-Generation Sequencing (NGS) Approach 30
Impact of ABCG2 and ABCB1 Polymorphisms on Imatinib Plasmatic Exposure: An Original Work and Meta-Analysis 30
Identification of Novel Somatic TP53 Mutations in Patients with High-Grade Serous Ovarian Cancer (HGSOC) Using Next-Generation Sequencing (NGS) 30
Correction: Cisplatin resistance can be curtailed by blunting Bnip3-mediated mitochondrial autophagy (Cell Death & Disease, (2022), 13, 4, (398), 10.1038/s41419-022-04741-9) 29
European association for clinical pharmacology and therapeutics young clinical pharmacologists working group: a cornerstone for the brighter future of clinical pharmacology 28
Body mass index impacts adverse events and drug plasma concentration: should dose intensity be included in the palbociclib equation? 28
Pharmacogenetic score predicts overall survival, progression-free survival and platinum sensitivity in ovarian cancer 28
Cancer Pharmacogenetics: perspective on newly discovered and implemented predictive biomarkers 28
Pregnane X receptor, constitutive androstane receptor and hepatocyte nuclear factors as emerging players in cancer precision medicine 27
Candidate germline polymorphisms of genes belonging to the pathways of four drugs used in osteosarcoma standard chemotherapy associated with risk, survival and toxicity in non-metastatic high-grade osteosarcoma 27
Clinical validity of a DPYD-based pharmacogenetic test to predict severe toxicity to fluoropyrimidines 27
Ubiquitous Pharmacogenomics (U-PGx): The Time for Implementation is Now. An Horizon2020 Program to Drive Pharmacogenomics into Clinical Practice 26
Cisplatin resistance can be curtailed by blunting Bnip3-mediated mitochondrial autophagy 26
Inositol and Non-Alcoholic Fatty Liver Disease: A Systematic Review on Deficiencies and Supplementation 26
Genetic biomarkers for hepatocellular cancer risk in a caucasian population 25
Improving decision making on DPYD and UGT1A1*28 patients' profiling with an innovative reimbursement strategy 25
Clinical Benefits and Utility of Pretherapeutic DPYD and UGT1A1 Testing in Gastrointestinal Cancer 24
Germline Polymorphisms in the Nuclear Receptors PXR and VDR as Novel Prognostic Markers in Metastatic Colorectal Cancer Patients Treated With FOLFIRI 24
Association of STAT-3 rs1053004 and VDR rs11574077 With FOLFIRI-Related Gastrointestinal Toxicity in Metastatic Colorectal Cancer Patients 24
The burden of rare variants in DPYS gene is a novel predictor of the risk of developing severe fluoropyrimidine-related toxicity 22
Exploring pharmacokinetic variability of palbociclib in HR+/HER2- metastatic breast cancer: a focus on age, renal function, and drug–gene interactions 22
CDK4/6 Inhibitors in Breast Cancer Treatment: Potential Interactions with Drug, Gene, and Pathophysiological Conditions 22
Pharmacogenomics of Targeted Agents for Personalization of Colorectal Cancer Treatment 22
Ten-year experience with pharmacogenetic testing for DPYD in a national cancer center in Italy: Lessons learned on the path to implementation 20
Quantification of Letrozole, Palbociclib, Ribociclib, Abemaciclib, and Metabolites in Volumetric Dried Blood Spots: Development and Validation of an LC-MS/MS Method for Therapeutic Drug Monitoring 19
mHealth Apps Available in Italy to Support Health Care Professionals in Antimicrobial Stewardship Implementation: Systematic Search in App Stores and Content Analysis 18
Cost-utility analysis and cross-country comparison of pharmacogenomics-guided treatment in colorectal cancer patients participating in the U-PGx PREPARE study 17
Totale 2.276
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.753
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.753
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205 0 0 0 0 0 0 0 0 0 0 0 5
2020/2021127 3 6 19 16 8 11 28 11 8 5 7 5
2021/202266 3 5 0 4 2 2 11 0 4 10 14 11
2022/2023318 9 3 4 77 59 70 0 22 45 4 9 16
2023/2024339 31 19 11 4 39 40 21 15 19 31 25 84
2024/20251.196 53 87 42 40 88 71 91 61 126 100 225 212
Totale 2.276